Skip to main content
81618 search results for:

Arterial Hypertension 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 10-05-2024 | Online First

    Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension

    This retrospective chart review of patients less than 18 years old with pulmonary arterial hypertension (PAH) receiving selexipag was conducted to describe selexipag dosing practices, impact on concomitant PAH therapies, and the safety and …

  2. Open Access 01-12-2024 | Pulmonary Hypertension | OriginalPaper

    Fractional exhaled nitric oxide in idiopathic pulmonary arterial hypertension and mixed connective tissue disease complicating pulmonary hypertension

    PH is a rare and progressive disease that can have several potential etiologies and is associated with respiratory and cardiovascular diseases. It is characterized by elevated lung vascular resistance, ultimately leading to premature death [ 1 ].

  3. Open Access 01-12-2024 | Arterial Hypertension | ReviewPaper

    Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics

    This review examines how single-cell omics technologies, particularly single-cell RNA sequencing (scRNAseq), enhance our understanding of pulmonary arterial hypertension (PAH). PAH is a multifaceted disorder marked by pulmonary vascular …

  4. 08-05-2024 | Pulmonary Hypertension | Online First

    Correlation of Pulmonary Arterial Hypertension with Laboratory Parameters in Sickle Cell Disease- A Retrospective Study

    To study the prevalence of pulmonary arterial hypertension (PAH) in individuals with sickle cell disease (SCD) and its relationship with serological markers. Data of ninety-two SCD patients who visited the Department of Clinical Haematology …

  5. 30-04-2024 | ECMO | Online First

    ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension

    Idiopathic pulmonary arterial hypertension (IPAH) represents an important clinical indication for lung transplant (LTx) in children. Recent trends show fewer children with IPAH are undergoing LTx nowadays compared to previous time periods …

  6. Open Access 01-12-2024 | Biomarkers | OriginalPaper

    Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension

    Pulmonary arterial hypertension (PAH) is a fatal pulmonary vascular disease which is marked by elevated pressure and the failure of the right ventricle [ 1 , 2 ]. Despite the significant progress in enhancing survival through the advancement of …

  7. Open Access 01-12-2024 | Arterial Hypertension | OriginalPaper

    Combined physical training protects the left ventricle from structural and functional damages in experimental pulmonary arterial hypertension

    Pulmonary arterial hypertension (PAH) is a chronic debilitating illness in which the increase in pulmonary vascular resistance and the remodeling of the pulmonary artery induces pressure-overload in the right ventricle (RV) ending thus in …

  8. Open Access 01-12-2024 | Arterial Hypertension | OriginalPaper

    Neutrophil extracellular traps promote proliferation of pulmonary smooth muscle cells mediated by CCDC25 in pulmonary arterial hypertension

    Pulmonary arterial hypertension (PAH) is a common clinical disease that affects at least 1% of the global population [ 1 , 2 ]. PAH is a heterogeneous clinical disease characterized by abnormally elevated pulmonary arterial pressure, which is …

  9. 27-04-2024 | Systemic Sclerosis | Online First

    Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era—results from a nationwide study

    Systemic sclerosis (SSc) is a rare connective tissue disease characterized by vasculopathy, immune activation, and fibrosis of skin and internal organs [ 1 ]. Pulmonary arterial hypertension (PAH) is a severe vascular complication of SSc caused by …

  10. Open Access 22-03-2024 | Arterial Hypertension | ReviewPaper

    Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications

    Pulmonary arterial hypertension is characterized by elevated blood pressure and pathological changes in the pulmonary arterioles, leading to the development of right-heart failure and potentially fatal outcomes if left untreated. This review aims …

  11. Open Access 01-12-2024 | Respiratory Microbiota | OriginalPaper

    Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study

  12. Open Access 26-03-2024 | Hypertension | OriginalPaper

    Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence

    Globally, hypertension is the most significant modifiable risk factor of cardiovascular (CV) morbidity and mortality in women and ranks second only to tobacco smoking in men [ 1 ]. Achieving blood pressure (BP) control is crucial for reducing the …

  13. Open Access 06-04-2024 | Arterial Hypertension | Online First

    Arterial hypertension in infants with congenital diaphragmatic hernia following surgical repair

    Pulmonary hypertension (PH) and cardiac dysfunction are established comorbidities of congenital diaphragmatic hernia (CDH). However, there is very little data focusing on arterial hypertension in CDH. This study aims to investigate the incidence …

  14. Open Access 01-12-2024 | Insulins | OriginalPaper

    Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study

    Pulmonary arterial hypertension (PAH) is characterized by the progressive elevation of pulmonary artery pressure and pulmonary vascular resistance, ultimately resulting in right heart failure and even mortality. It represents an advanced stage of …

  15. Open Access 01-12-2024 | Arterial Hypertension | OriginalPaper

    Serum PM20D1 levels in patients with idiopathic pulmonary arterial hypertension and its clinical significance

    Pulmonary Arterial Hypertension (PAH) is a serious pulmonary vascular disease characterized by elevated resting mean pulmonary arterial pressure (mPAP) [ 1 ]. PAH affects the function of pulmonary arteries and pulmonary capillaries, leading to …

  16. Open Access 15-04-2024 | Pulmonary Hypertension | Online First

    Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype

    A growing number of patients diagnosed with pulmonary arterial hypertension (PAH) has features suggestive of concomitant left heart disease (LHD), albeit not clinically overt, nor sufficient to cause an elevation in pulmonary artery wedge pressure …

  17. 18-04-2024 | Arterial Hypertension | Online First

    When pulmonary arterial hypertension complicates connective tissue diseases: we still have not found what we are looking for

  18. Open Access 20-02-2024 | Systemic Sclerosis | OriginalPaper

    Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis

    The evidence for the treatment of connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) mostly depends on subgroup or post hoc analysis of randomized controlled trials (RCTs). Thus, we performed a meta-analysis of RCTs …

  19. Open Access 01-12-2024 | Chronic Kidney Disease | ReviewPaper

    Strategies to prevent, diagnose and treat kidney disease related to systemic arterial hypertension: a narrative review from the Mexican Group of Experts on Arterial Hypertension

    This narrative review highlights strategies proposed by the Mexican Group of Experts on Arterial Hypertension endorsed to prevent, diagnose, and treat chronic kidney disease (CKD) related to systemic arterial hypertension (SAH). Given the growing …

  20. Open Access 16-02-2024 | Ambrisentan | OriginalPaper

    Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

    This open-label, extension study assessed long-term safety, tolerability, and efficacy of ambrisentan in a pediatric population (age 8– < 18 years) with pulmonary arterial hypertension (PAH). Following completion of a 6-month, randomized study …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.